10.57
Kodiak Sciences Inc Aktie (KOD) Neueste Nachrichten
Why Kodiak Sciences Inc. stock attracts strong analyst attentionPortfolio Gains Report & High Return Trade Guides - thegnnews.com
Kodiak Q2 Loss Wider Than Expected, Pipeline Development in Focus - MSN
Real time pattern detection on Kodiak Sciences Inc. stockEarnings Risk Report & Consistent Growth Equity Picks - Newser
Will Kodiak Sciences Inc. stock benefit from interest rate changesJuly 2025 Intraday Action & AI Powered Buy and Sell Recommendations - Newser
How to build a custom watchlist for Kodiak Sciences Inc.2025 Key Lessons & Weekly Top Gainers Trade List - Newser
Kodiak Sciences (KOD) up more than 100% since Jul 22 - AInvest
Kodiak Q2 Loss Wider Than Expected, Pipeline Development In Focus - Barchart.com
Barclays maintains Underweight rating for Kodiak Sciences, raises PT to $7. - AInvest
J.P. Morgan Upgrades Kodiak Sciences(KOD.US) to Hold Rating, Announces Target Price $15 - 富途牛牛
JPMorgan Upgrades Kodiak Sciences to Neutral From Underweight, Price Target is $15 - MarketScreener
JP Morgan upgrades Kodiak Sciences to Neutral, raises PT to $15. - AInvest
JPMorgan upgrades Kodiak Sciences stock rating to Neutral from Underweight - Investing.com
Kodiak Sciences Beats Q2 Loss Estimates - AOL.com
Combining machine learning predictions for Kodiak Sciences Inc.July 2025 Patterns & Fast Moving Trade Plans - Newser
Kodiak Sciences Reports Q2 2025 Financial Results and Clinical Progress - TipRanks
Published on: 2025-08-13 23:53:41 - Newser
What moving averages say about Kodiak Sciences Inc.2025 Earnings Impact & Safe Capital Allocation Plans - Newser
What makes Kodiak Sciences Inc. stock price move sharplyTrade Ideas & Weekly Breakout Opportunity Watchlist - Newser
Kodiak Sciences reports Q2 2025 financial results, highlights recent business highlights. - AInvest
Kodiak Sciences Q2 Loss Widens - MarketScreener
Kodiak Sciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Kodiak Sciences Q2 Earnings: Net Loss Exceeds Expectations - AInvest
Kodiak Sciences Q2 net loss misses estimates - MarketScreener
Kodiak's Eye Disease Drug Shows 90% Success Rate in Phase 1b Trial, Pipeline Advances - Stock Titan
Is Kodiak Sciences Inc. stock entering bullish territoryWeekly Investment Recap & AI Optimized Trading Strategy Guides - Newser
How to integrate Kodiak Sciences Inc. into portfolio analysis toolsMarket Rally & Community Verified Watchlist Alerts - Newser
Technical signs of recovery in Kodiak Sciences Inc.Weekly Volume Report & AI Driven Price Predictions - Newser
What high frequency data says about Kodiak Sciences Inc.Future Growth Stock Forecasting Strategy - Newser
Kodiak Sciences Inc. Shows Support at Fibonacci LevelMarket Momentum and Signal Alerts Suggest Reversal - sundaytimes.kr
Is Kodiak Sciences Inc. meeting your algorithmic filter criteriaFree Weekly Hot Picks With Buy Confidence - Newser
Key metrics from Kodiak Sciences Inc.’s quarterly dataWatchlist Generator With Real-Time Entry - Newser
Combining machine learning predictions for Kodiak Sciences IncConsistent Profit Signals with AI Models - Newser
Is Kodiak Sciences Inc. Stock a Good Fit for Conservative InvestorsProfitable Trading Blueprint with Entry Zones - Newser
Forecasting Kodiak Sciences Inc. price range with options dataBuy and Hold Return Summary with Charts - Newser
Is Kodiak Sciences Inc. showing signs of accumulationEntry Zone Forecast for Momentum Trading - Newser
How Kodiak Sciences Inc. stock performs during market volatilitySecure Entry Point Finder with Analysis - Newser
Real time breakdown of Kodiak Sciences Inc. stock performanceReal Market Tracker with Price Action Tools - Newser
Strategies to average down on Kodiak Sciences Inc.Free Multi-Bagger Potential Stock Forecast Tools - Newser
What does recent volatility data suggest for Kodiak Sciences Inc.Real Market Tracker with Price Action Tools - Newser
Multi asset correlation models including Kodiak Sciences Inc.Predictive Analytics for Equity Growth Potential - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):